Key statistics
On Friday, argenx SE (1AEA:HAN) closed at 474.00, 13.40% above the 52 week low of 418.00 set on Jul 23, 2024.
52-week range
Short selling activityProvided by S&P Global Market Intelligence
Open | 476.00 |
---|---|
High | 476.00 |
Low | 474.00 |
Bid | 476.00 |
Offer | 484.00 |
Previous close | 480.00 |
Average volume | 0.00 |
---|---|
Shares outstanding | 61.20m |
Free float | 60.88m |
P/E (TTM) | 35.03 |
Market cap | 34.81bn USD |
EPS (TTM) | 16.08 USD |
Data delayed at least 15 minutes, as of Jul 11 2025 16:25 BST.
More ▼
Announcements
- argenx Advances Clinical Development of ARGX-119 in Congenital Myasthenic Syndromes
- argenx Announces European Commission Approval of VYVGART Subcutaneous Injection for Chronic Inflammatory Demyelinating Polyneuropathy
- argenx Presents New Efgartigimod Data at EULAR 2025 Highlighting Positive Phase 2 Proof-of-Concept Results in Myositis and Sjogren’s Disease
- argenx to Present at Goldman Sachs 46th Annual Global Healthcare Conference
- argenx Announces Results of Annual General Meeting of Shareholders
- argenx Reports First Quarter 2025 Financial Results and Provides Business Update
- argenx to Present at BofA Securities 2025 Health Care Conference
- argenx to Report First Quarter 2025 Financial Results and Business Update on May 8, 2025
- argenx Announces Positive CHMP Opinion for VYVGART (efgartigimod alfa) Subcutaneous Injection for Chronic Inflammatory Demyelinating Polyneuropathy (CIDP)
- argenx Announces Annual General Meeting of Shareholders on May 27, 2025
More ▼